tradmap

IBO IMPACT BIOMEDICAL INC.

$0.48 -1.16%

Updated

Healthcare · Pharmaceutical Preparations

IMPACT BIOMEDICAL INC. (IBO) is a healthcare company in the Pharmaceutical Preparations industry, with a market capitalization of $52 million. Shares last traded at $0.48, 54.4% below their 52-week high. Over the past year the stock is down 13.6%. IBO trades at a price-to-earnings ratio of 66.10, above the Pharmaceutical Preparations median of 17.31. Revenue declined 36.0% year over year.

Market Cap
$52M
Shares Out
107.8M
EPS (TTM)
$-2.75
P/E Ratio
66.10
P/S Ratio
1490.09
P/B Ratio
4.84
Dividend / Share
Dividend Yield
52-Week High
$1.06
52-Week Low
$0.40
Volume
10
Avg Vol (3m)
768.095

Performance

1W
+9.68%
1M
+10.23%
3M
-5.31%
6M
+10.28%
YTD
+0.17%
1Y
-13.64%

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)
56.81
SMA (50)
$0.46
SMA (200)
$0.52
Price vs SMA50
+4.17%
Price vs SMA200
-6.42%
ATR (14)
$0.02

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue
$0M
Net Income
$1M
Gross Margin
Operating Margin
Net Margin
Return on Equity
7.3%
Return on Assets
4.7%
Current Ratio
0.16
Debt / Equity
0.25
Revenue Growth (YoY)
-36.0%

Latest reported annual period ending 2026-06-30 · SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

PeriodEPS (diluted)Reported
Q2 2026 $-0.03 2026-08-07
Q1 2026 $-0.02 2026-05-12
FY 2025 $-0.38 2026-03-11
Q3 2025 $-1.41 2025-11-07
Q2 2026 $-1.29 2026-08-07
Q1 2026 $-0.11 2026-05-12

Full earnings history →

Pharmaceutical Preparations peers

IBO vs 14 industry peers (Pharmaceutical Preparations), by market cap. Updated

P/E vs peers
66.10 / 17.31 med
+282% premium
P/S vs peers
1490.09 / 11.11 med
+13314% premium
1–14 of 14
LLYLilly (Eli)$1.09T40.8613.7033.5%-0.02%
JNJJohnson & Johnson$670.6B31.886.8521.5%+1.04%
ONCBeone Medicines Ltd.$535.9B817.2587.4310.7%+0.23%
ABBVAbbVie$459.8B72.877.149.8%-0.57%
MRKMerck$375.8B118.445.654.8%+0.44%
ABTAbbott Laboratories$189.5B30.204.2013.9%-1.50%
PFEPfizer$164.2B37.912.586.8%-0.76%
VRTXVertex Pharmaceuticals$141.5B32.1111.2435.0%+0.24%
BMYBristol Myers Squibb$139.1B14.982.8318.9%+0.62%
REGNRegeneron Pharmaceuticals$87.2B20.155.6127.9%-1.02%
TEVATeva Pharmaceutical Industries Ltd$42.6B60.412.464.1%-2.32%
ALNYAlnylam Pharmaceuticals$35.4B43.779.5221.8%-1.10%
ZTSZoetis$31.5B12.053.3127.5%+0.16%
RPRXRoyalty Pharma Plc$28.2B34.5611.1132.1%+1.24%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.